BioMed Central | Members | Novartis Group

Submit a manuscript Register Contact us

Institution search

Search by institution name/city

Members

Australia (21)
Austria (6)
Belgium (3)
Brazil (4)
Burkina Faso (1)
Canada (27)
Central African Republic (1)
China (3)
Cyprus (3)
Czech Republic (1)
Denmark (1)
Ethiopia (1)
Finland (6)
France (7)
Germany (51)
Ghana (3)
Greece (1)
Hong Kong (2)
Hungary (1)
India (7)
Ireland (1)
Israel (1)
Italy (14)
Kenya (3)
Korea, South (2)
Lebanon (1)
Lithuania (1)
Luxembourg (1)
Madagascar (1)
Malaysia (3)
Mexico (1)
Morocco (2)
Netherlands (10)
New Zealand (1)
Nigeria (2)
Norway (4)
Poland (2)
Portugal (1)
Romania (1)
South Africa (6)
Spain (14)
Sweden (9)
Switzerland (10)
Taiwan (3)
Tanzania (2)
Thailand (1)
Trinidad and Tobago (1)
Turkey (1)
Uganda (1)
United Kingdom (49)
United States of America (157)

Advertisement

Member - Novartis Group

Novartis is a world leader in the research and development of products to protect and improve health and well-being.

http://www.novartis.com/

Research staff and students at Novartis Group:

Do you realize that you can now publish in journals published by BioMed Central without directly paying any article-processing charges? Payment of your article-processing charges is covered by Novartis Group's Prepay Membership. Read more information about publishing your articles with us.

Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Novartis Group

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	76.	Methodology article *Whole genome sequencing analysis of Plasmodium vivax* using whole genome capture** A Bright, Ryan Tewhey, Shira Abeles, Raul Chuquiyauri, Alejandro Llanos-Cuentas, Marcelo U Ferreira, Nicholas J Schork, Joseph M Vinetz, Elizabeth A Winzeler BMC Genomics 2012, 13:262 (21 June 2012) Abstract \| Full text \| PDF \| PubMed
	77.	Original clinical investigation Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement Peter Bramlage, Hans-Christoph Michaelis, Nima Melzer Thrombosis Journal 2012, 10:10 (19 June 2012) Abstract \| Full text \| PDF \| PubMed
	78.	Original research PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with ¹⁷⁷Lu-DOTA-bombesin analogues Simone Däpp, Cristina Müller, Elisa Garayoa, Peter Bläuenstein, Veronique Maes, Luc Brans, Dirk A Tourwé, Roger Schibli EJNMMI Research 2012, 2:24 (9 June 2012) Abstract \| Full text \| PDF \| PubMed
	79.	Comment Se-Jin Lee, myostatin discoverer, elected to the National Academy of Science David J Glass, Bruce M Spiegelman Skeletal Muscle 2012, 2:11 (7 June 2012) Abstract \| Full text \| PDF \| PubMed
	80.	Research article Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs Suleiman A Khan, Ali Faisal, John Mpindi, Juuso A Parkkinen, Tuomo Kalliokoski, Antti Poso, Olli P Kallioniemi, Krister Wennerberg, Samuel Kaski BMC Bioinformatics 2012, 13:112 (30 May 2012) Abstract \| Full text \| PDF \| PubMed
	81.	Research article Medical student attitudes towards family medicine in Spain: a statewide analysis Amando Zurro, Josep Villa, Antonio Hijar, Xavier Tuduri, Ángel Puime, Pablo Alonso-Coello, BMC Family Practice 2012, 13:47 (29 May 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	82.	Methodology article Natural product-likeness score revisited: an open-source, open-data implementation Kalai Vanii, Pablo Moreno, Andreas Truszkowski, Peter Ertl, Christoph Steinbeck BMC Bioinformatics 2012, 13:106 (20 May 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	83.	Research Determination of minimal transcriptional signatures of compounds for target prediction Florian Nigsch, Janna Hutz, Ben Cornett, Douglas W Selinger, Gregory McAllister, Somnath Bandyopadhyay, Joseph Loureiro, Jeremy L Jenkins EURASIP Journal on Bioinformatics and Systems Biology 2012, 2012:2 (10 May 2012) Abstract \| Full text \| PDF \| PubMed
	84.	Research article Acceptability – a neglected dimension of access to health care: findings from a study on childhood convulsions in rural Tanzania Angel Dillip, Sandra Alba, Christopher Mshana, Manuel W Hetzel, Christian Lengeler, Iddy Mayumana, Alexander Schulze, Hassan Mshinda, Mitchell G Weiss, Brigit Obrist BMC Health Services Research 2012, 12:113 (9 May 2012) Abstract \| Full text \| PDF \| PubMed
	85.	Review *A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum* malaria during pregnancy** Christine Manyando, Kassoum Kayentao, Umberto D’Alessandro, Henrietta U Okafor, Elizabeth Juma, Kamal Hamed Malaria Journal 2012, 11:141 (1 May 2012) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary There is evidence to suggest that the pharmacokinetics of anti-malarial drugs may change in pregnancy, although the majority of studies report high cure rates and adequate tolerability. The paper reinforces the WHO recommendation to treat uncomplicated falciparum malaria with quinine plus clindamycin in early pregnancy and ACT in later pregnancy.
	86.	Research *Therapeutic efficacy of milbemycin oxime/praziquantel oral formulation (Milbemax®) against Thelazia callipaeda* in naturally infested dogs and cats** Bruna Motta, Manuela Schnyder, Fabrizio Basano, Fabio Nägeli, Catherine Nägeli, Brigitte Schiessl, Egidio Mallia, Riccardo P Lia, Filipe Dantas-Torres, Domenico Otranto Parasites & Vectors 2012, 5:85 (27 April 2012) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary In a placebo controlled field study conducted with 56 dogs and 31cats from Thelazia callipaeda endemic areas of Switzerland and Italy the commercial formulation Milbemax (milbemycin oxime/praziquantel tablets) showed a high therapeutic efficacy in curing T. callipaeda infestations. Image: Eye of a cat from Basilicata (Italy) infested with several adult specimens of Thelazia callipaeda.
	87.	Research The ion channel transient receptor potential melastatin-2 does not play a role in inflammatory mouse models of chronic obstructive pulmonary diseases Liz Hardaker, Parmjit Bahra, Benjamin de Billy, Mark Freeman, Natalia Kupfer, Daniel Wyss, Alexandre Trifilieff Respiratory Research 2012, 13:30 (4 April 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	88.	Research article Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor Aiying Wang, Charles Dorso, Lisa Kopcho, Gregory Locke, Robert Langish, Eric Harstad, Petia Shipkova, Jovita Marcinkeviciene, Lawrence Hamann, Mark S Kirby BMC Pharmacology 2012, 12:2 (4 April 2012) Abstract \| Full text \| PDF \| PubMed
	89.	Research NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity Emmanouil Fokas, Michio Yoshimura, Remko Prevo, Geoff Higgins, Wolfgang Hackl, Sauveur-Michel Maira, Eric J Bernhard, W Gillies McKenna, Ruth J Muschel Radiation Oncology 2012, 7:48 (27 March 2012) Abstract \| Full text \| PDF \| PubMed
	90.	Research article A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia Marco DiBonaventura, Susan Gabriel, Leon Dupclay, Shaloo Gupta, Edward Kim BMC Psychiatry 2012, 12:20 (20 March 2012) Abstract \| Full text \| PDF \| PubMed
	91.	Research article The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro Elisabetta Tabolacci, Filomena Pirozzi, Baltazar Gomez-Mancilla, Fabrizio Gasparini, Giovanni Neri BMC Medical Genetics 2012, 13:13 (7 March 2012) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary The beneficial effect of Fragile X syndrome (FXS) drug AFQ056 for patients with fully methylated FMR1 genes does not act through a secondary effects on FMR1 mRNA production or promoter methylation, in FXS lymphoblastoid cell lines.
	92.	Research article Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis Altan Ercan, Jing Cui, Melissa M Hazen, Franak Batliwalla, Louise Royle, Pauline M Rudd, Jonathan S Coblyn, Nancy Shadick, Michael E Weinblatt, Peter Gregersen, David M Lee, Peter A Nigrovic Arthritis Research & Therapy 2012, 14:R43 (5 March 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	93.	Research Discoidin domain receptors regulate the migration of primary human lung fibroblasts through collagen matrices Pedro A Ruiz, Gabor Jarai Fibrogenesis & Tissue Repair 2012, 5:3 (15 February 2012) Abstract \| Full text \| PDF \| PubMed
	94.	Research TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A Anne Trendelenburg, Angelika Meyer, Carsten Jacobi, Jerome N Feige, David J Glass Skeletal Muscle 2012, 2:3 (7 February 2012) Abstract \| Full text \| PDF \| PubMed
	95.	Research article Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in cats B Duncan X Lascelles, Yaa-Hui Dong, Denis J Marcellin-Little, Andrea Thomson, Simon Wheeler, Maria Correa BMC Veterinary Research 2012, 8:10 (27 January 2012) Abstract \| Full text \| PDF \| PubMed
	96.	Research article Predicting the mechanism of phospholipidosis Robert Lowe, Hamse Y Mussa, Florian Nigsch, Robert C Glen, John BO Mitchell Journal of Cheminformatics 2012, 4:2 (26 January 2012) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary \| Graphical abstract An in silico approach was used to predict targets for phospholipidosis, a lysosomal disorder characterized by accumulation of phospholipids in tissues. By predicting targets for a database of compounds, they can be ranked by their potential to cause phospholipidosis
	97.	Research The new pLAI (lux regulon based auto-inducible) expression system for recombinant protein production in Escherichia coli Salvatore Nocadello, Erwin Swennen Microbial Cell Factories 2012, 11:3 (5 January 2012) Abstract \| Full text \| PDF \| PubMed
	98.	Editorial Skeletal Muscle - one year on David Glass, Kevin Campbell, Michael Rudnicki Skeletal Muscle 2012, 2:1 (5 January 2012) Abstract \| Full text \| PDF \| PubMed
	99.	Research Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis Paul W Jones, James F Donohue, Jerry Nedelman, Steve Pascoe, Gregory Pinault, Cheryl Lassen Respiratory Research 2011, 12:161 (29 December 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	100.	Research article Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study Chris M Kozma, Andrew L Paris, Craig A Plauschinat, Terra Slaton, John I Mackowiak BMC Pulmonary Medicine 2011, 11:61 (22 December 2011) Abstract \| Full text \| PDF \| PubMed